embelin has been researched along with Prostatic Neoplasms in 7 studies
embelin: from Embelia fruit (Myrsinaceae)
embelin : A member of the class of dihydroxy-1,4-benzoquinones that is 2,5-dihydroxy-1,4-benzoquinone which is substituted by an undecyl group at position 3. Isolated from Lysimachia punctata and Embelia ribes, it exhibits antimicrobial, antineoplastic and inhibitory activity towards hepatitis C protease.
Prostatic Neoplasms: Tumors or cancer of the PROSTATE.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Embelin is a natural product and exhibits antitumor activity through blocking the activity of X-linked inhibitor of apoptosis protein (XIAP)." | 1.39 | PEG-derivatized embelin as a nanomicellar carrier for delivery of paclitaxel to breast and prostate cancers. ( Gao, X; Huang, Y; Li, J; Li, S; Lu, J; Marquez, RT; Meng, X; Venkataramanan, R; Wang, Z; Zhao, W, 2013) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 6 (85.71) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Park, N | 1 |
| Baek, HS | 1 |
| Chun, YJ | 1 |
| Danquah, M | 3 |
| Li, F | 2 |
| Duke, CB | 2 |
| Miller, DD | 2 |
| Mahato, RI | 3 |
| Heo, JY | 1 |
| Kim, HJ | 1 |
| Kim, SM | 2 |
| Park, KR | 1 |
| Park, SY | 1 |
| Kim, SW | 2 |
| Nam, D | 2 |
| Jang, HJ | 1 |
| Lee, SG | 2 |
| Ahn, KS | 4 |
| Kim, SH | 2 |
| Shim, BS | 2 |
| Choi, SH | 2 |
| Patil, R | 1 |
| Bae, H | 1 |
| Lee, JH | 1 |
| Sethi, G | 1 |
| Lu, J | 1 |
| Huang, Y | 1 |
| Zhao, W | 1 |
| Marquez, RT | 1 |
| Meng, X | 1 |
| Li, J | 1 |
| Gao, X | 1 |
| Venkataramanan, R | 1 |
| Wang, Z | 1 |
| Li, S | 1 |
7 other studies available for embelin and Prostatic Neoplasms
| Article | Year |
|---|---|
Embelin-Induced Apoptosis of Human Prostate Cancer Cells Is Mediated through Modulation of Akt and β-Catenin Signaling.
Topics: Apoptosis; Benzoquinones; beta Catenin; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cycloox | 2015 |
Micellar delivery of bicalutamide and embelin for treating prostate cancer.
Topics: Anilides; Animals; Antineoplastic Agents; Apoptosis; Base Sequence; Benzoquinones; Cell Line, Tumor; | 2009 |
Synthesis and characterization of amphiphilic lipopolymers for micellar drug delivery.
Topics: Antineoplastic Agents; Benzoquinones; Calorimetry, Differential Scanning; Cell Line, Tumor; Cell Pro | 2010 |
Embelin suppresses STAT3 signaling, proliferation, and survival of multiple myeloma via the protein tyrosine phosphatase PTEN.
Topics: Apoptosis; Benzoquinones; Caspase 3; Cell Cycle; Cell Growth Processes; Cell Line, Tumor; DNA, Neopl | 2011 |
Combination therapy of antiandrogen and XIAP inhibitor for treating advanced prostate cancer.
Topics: Androgen Antagonists; Anilides; Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy | 2012 |
Embelin inhibits growth and induces apoptosis through the suppression of Akt/mTOR/S6K1 signaling cascades.
Topics: Androgens; Apoptosis; Benzoquinones; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cell Survival | 2013 |
PEG-derivatized embelin as a nanomicellar carrier for delivery of paclitaxel to breast and prostate cancers.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Benzoquinones; Breast Neoplasms; Cell Line, | 2013 |